VR Adviser, LLC
13F Portfolio Filings
Most recent 13F Q1 2026Location new york, NYCIK 0001615982Alternate names Venrock Adviser, LLCAll SEC filings
Q1 2026 Summary
Quarter | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
33 | $2.68B | APGE, ERAS, ORUKA THERAPEUTICS INC, SYRE | 13F-HR | May 15, 2026 | 000161598226000011 | ||
27 | $2.02B | APGE, ORUKA THERAPEUTICS INC, VRDN, SYRE | 13F-HR | Feb 17, 2026 | 000161598226000005 | ||
33 | $1.78B | APGE, METSERA INC, OCUL, CDTX | 13F-HR | Nov 14, 2025 | 000161598225000006 | ||
31 | $1.33B | APGE, OCUL, METSERA INC, ELVN | 13F-HR | Aug 14, 2025 | 000141588925021914 | ||
37 | $1.18B | APGE, METSERA INC, OCUL, ELVN | 13F-HR | May 15, 2025 | 000141588925013093 | ||
37 | $1.46B | APGE, OCUL, ELVN, PRAX | 13F-HR | Feb 14, 2025 | 000110465925014110 | ||
38 | $1.91B | APGE, OCUL, ELVN, VRDN | 13F-HR | Nov 14, 2024 | 000110465924118950 | ||
35 | $1.57B | APGE, ELVN, FDMT, OCUL | 13F-HR | Aug 14, 2024 | 000110465924089632 | ||
38 | $2.1B | APGE, FDMT, OCUL, SYRE | 13F-HR | May 15, 2024 | 000110465924061948 | ||
36 | $1.46B | RYZB, APGE, PHARVARIS N V, VRDN | 13F-HR | Feb 14, 2024 | 000110465924023659 | ||
37 | $949.95M | APGE, RYZB, VRDN, COGT | 13F-HR | Nov 14, 2023 | 000110465923118127 | ||
30 | $625.36M | VRDN, COGT, FDMT, ELVN | 13F-HR | Aug 11, 2023 | 000110465923090491 | ||
25 | $512.17M | VRDN, COGT, ELVN, TERN | 13F-HR | May 15, 2023 | 000110465923060793 | ||
28 | $593.61M | VRDN, ACRS, AXSM, COGT | RESTATEMENT | May 15, 2023 | 000110465923060789 | ||
31 | $648.09M | TRICIDA INC, ACRS, COGT, RLMD | RESTATEMENT | May 15, 2023 | 000110465923060784 | ||
27 | $507.78M | TRICIDA INC, ACRS, RLMD, TRAVERE THERAPEUTICS INC | RESTATEMENT | May 15, 2023 | 000110465923060779 | ||
27 | $617.24M | ACRS, TIL, RLMD, TRAVERE THERAPEUTICS INC | 13F-HR | May 16, 2022 | 000110465922061286 | ||
26 | $731.54M | TIL, ACRS, TRAVERE THERAPEUTICS INC, RLMD | 13F-HR | Feb 14, 2022 | 000110465922022702 | ||
26 | $778.55M | TIL, ACRS, TCE2, AADI | 13F-HR | Nov 15, 2021 | 000110465921139155 | ||
29 | $824.4M | TIL, ACRS, VTGN, GRAPHITE BIO INC | 13F-HR | Aug 13, 2021 | 000110465921105075 | ||
28 | $921.76M | TIL, CNST, ACRS, OLMA | 13F-HR | May 14, 2021 | 000110465921066847 | ||
25 | $680.15M | CNST, OLMA, TRILLIUM THERAPEUTICS INC, KNTE | 13F-HR | Feb 12, 2021 | 000110465921021905 | ||
22 | $511.17M | TRILLIUM THERAPEUTICS INC, CNST, ALT, ATHA | 13F-HR | Nov 16, 2020 | 000110465920125774 | ||
16 | $417.63M | CNST, TRILLIUM THERAPEUTICS INC, ALT, RLMD | 13F-HR | Aug 14, 2020 | 000110465920095569 | ||
16 | $369.18M | CNST, AXSM, RLMD, TRILLIUM THERAPEUTICS INC | 13F-HR | May 15, 2020 | 000110465920062585 |